What is the official website of Lilly España ?

The official website of Lilly España is https://www.lilly.es.

What is Lilly España's cybersecurity risk score?

Lilly España has an AI-generated cybersecurity risk score of 759 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Lilly España experienced?

According to Rankiteo, Lilly España currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Lilly España been affected by any supply chain cyber incidents ?

According to Rankiteo, Lilly España has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Lilly España have SOC 2 Type 1 certification ?

According to Rankiteo, Lilly España is not certified under SOC 2 Type 1.

Does Lilly España have SOC 2 Type 2 certification ?

According to Rankiteo, Lilly España does not hold a SOC 2 Type 2 certification.

Does Lilly España comply with GDPR ?

According to Rankiteo, Lilly España is not listed as GDPR compliant.

Does Lilly España have PCI DSS certification ?

According to Rankiteo, Lilly España does not currently maintain PCI DSS compliance.

Does Lilly España comply with HIPAA ?

According to Rankiteo, Lilly España is not compliant with HIPAA regulations.

Does Lilly España have ISO 27001 certification ?

According to Rankiteo,Lilly España is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Lilly España operate in ?

Lilly España operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Lilly España have ?

Lilly España employs approximately None employees people worldwide.

Does Lilly España own any subsidiaries ?

Lilly España presently has no subsidiaries across any sectors.

How many LinkedIn followers does Lilly España have ?

Lilly España's official LinkedIn profile has approximately 25,149 followers.

What is the NAICS classification code for Lilly España ?

Lilly España is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Lilly España have a Crunchbase profile ?

No, Lilly España does not have a profile on Crunchbase.

Does Lilly España have a LinkedIn profile ?

Yes, Lilly España maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/lilly-espana.

How many cybersecurity incidents has Lilly España experienced ?

As of September 28, 2026, Rankiteo reports that Lilly España has not experienced any cybersecurity incidents.

How many peer or competitor companies does Lilly España have ?

Lilly España has an estimated 5,771 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Lilly España

Boost Score +25 with badge (5 left)

759

/1000

Fair

784

/1000

Fair

Lilly España Vendor Cyber Rating & Cyber Score

lilly.es

Add Your Compliance Badge

Durante casi 150 años, hemos sido pioneros en descubrimientos que cambian la vida y, hoy en día, nuestros medicamentos ayudan a más de 47 millones de personas en todo el mundo. Aprovechando el poder de la biotecnología, la química y la genética, nuestros científicos están avanzando sin descanso en nuevos hallazgos para resolver algunos de los desafíos de salud más importantes del mundo, redefiniendo el cuidado de la diabetes, tratando la obesidad y reduciendo sus efectos más devastadores a largo plazo, avanzando en la lucha contra la enfermedad de Alzheimer, proporcionando soluciones a algunos de los trastornos del sistema inmunológico más debilitantes y transformando los tumores más difíciles de tratar en enfermedades manejables. En

Lilly España

Lilly España CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Lilly España Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Lilly España

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Lilly España in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Lilly España in 2026.

Incident Types Lilly España vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Lilly España in 2026.

Incident History - Lilly España (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Lilly España Subsidiaries

Lilly España

Pharmaceutical Manufacturing

Website: https://www.lilly.es

Company Size: 1,001-5,000 employees

Eli Lilly and CompanyPharmaceutical Manufacturing

Eli Lilly ItaliaPharmaceutical Manufacturing

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyBiotechnology Research

Lilly IndiaPharmaceutical Manufacturing

Eli Lilly Australia & New ZealandPharmaceutical Manufacturing

Loading…

Lilly España Similar Companies

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Servier

servier.com

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Loading…

NEWS

Lilly España CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96284

SUMMARY

A malicious user can get read-access to files in the flatpak-system-helper context if a system OCI repository is configured, because the OCI code paths in the system helper follow symlinks when importing OCI images that are under the user's control.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 2.5)

cvss3

Base Score: 2.5

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

REFERENCES

CVE-2026-100886

SUMMARY

A vulnerability was identified in Seetong T8108, T8108P, T8116 and T8232 4.6.1.4-build202604241011. The affected element is an unknown function of the component Debug Service. Such manipulation leads to improper authentication. The attack may be launched remotely. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-100885

SUMMARY

A vulnerability was found in Krayin laravel-crm up to 2.2.4. This affects an unknown function of the file packages/Webkul/Installer/src/Http/Middleware/CanInstall.php of the component admin-config-setup API Endpoint. The manipulation results in authorization bypass. The attack may be launched remotely. The exploit has been made public and could be used. Upgrading to version 2.2.5 mitigates this issue. The patch is identified as 89f2916b6a46ff91bd1999ce38158fa0de8b9490. Upgrading the affected component is recommended.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-100884

SUMMARY

A vulnerability has been found in Krayin laravel-crm up to 2.2.5. The impacted element is the function Storage::download of the file packages/Webkul/Admin/src/Config/acl.php of the component attachment-download Endpoint. The manipulation of the argument ID leads to improper control of resource identifiers. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 2.2.6 is sufficient to resolve this issue. The identifier of the patch is 13d6988cda8d69ece45ee1890effc90a7f21cdc1. It is suggested to upgrade the affected component.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-100883

SUMMARY

A flaw has been found in Krayin laravel-crm up to 2.2.5. The affected element is an unknown function of the file packages/Webkul/Admin/src/Config/acl.php. Executing a manipulation can lead to improper access controls. The attack can be launched remotely. The exploit has been published and may be used. Upgrading to version 2.2.6 is sufficient to fix this issue. This patch is called a399404a388d8ad2700a01349d0d98069c8e85a4. The affected component should be upgraded.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Lilly España Vendor Cyber Rating & Cyber Score

Lilly España A.I CyberSecurity Scoring

Lilly España CyberSecurity News & History

Lilly España Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Lilly España

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Lilly España vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Lilly España (X = Date, Y = Severity)

Lilly España Subsidiaries

Lilly España

Lilly España Similar Companies

AbbVie

Catalent

SUN PHARMA

Zoetis

Novo Nordisk

Astellas Pharma

Lonza

Servier

Novartis

Lilly España CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Lilly España CyberSecurity News & History

Lilly España Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Lilly España

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Lilly España vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Lilly España (X = Date, Y = Severity)

Lilly España Subsidiaries

Lilly España

Lilly España Similar Companies

AbbVie

Catalent

SUN PHARMA

Zoetis

Novo Nordisk

Astellas Pharma

Lonza

Servier

Novartis

Lilly España CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo